|
🐜
|
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.
27 auth.
R. Soiffer,
T. Lynch,
M. Mihm,
K. Jung,
Catherine Rhuda,
J. Schmollinger,
F. Hodi,
L. Liebster,
P. Lam,
S. Mentzer,
Samuel Singer,
K. Tanabe,
Cosimi Ab,
Rosemary B. Duda,
A. Sober,
...
A. Bhan,
J. Daley,
D. Neuberg,
Gareth Parry,
J. Rokovich,
L. Richards,
J. Drayer,
A. Berns,
S. Clift,
L. Cohen,
R. Mulligan,
G. Dranoff
|
9 |
1998 |
9
🐜
|
|
🐜
|
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
7 auth.
L. Nadler,
K. Anderson,
G. Marti,
M. Bates,
E. Park,
J. Daley,
...
S. Schlossman
|
9 |
1983 |
9
🐜
|
|
🐜
|
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
9 auth.
Joachim L. Schultze,
S. Michalak,
M. Seamon,
G. Dranoff,
K. Jung,
J. Daley,
...
J. Delgado,
J. Gribben,
L. Nadler
|
8 |
1997 |
8
🐜
|
|
🐜
|
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
16 auth.
R. Prabhala,
Dheeraj Pelluru,
M. Fulciniti,
Harsha K. Prabhala,
P. Nanjappa,
Weihua Song,
Christine Pai,
S. Amin,
Y. Tai,
P. Richardson,
...
I. Ghobrial,
S. Treon,
J. Daley,
K. Anderson,
J. Kutok,
N. Munshi
|
8 |
2010 |
8
🐜
|
|
🐜
|
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
9 auth.
Linfeng Chen,
S. Monti,
P. Juszczyński,
J. Daley,
Wen Chen,
T. Witzig,
...
T. Habermann,
J. Kutok,
M. Shipp
|
8 |
2008 |
8
🐜
|
|
🐬
|
Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry.
M. Blue,
J. Daley,
H. Levine,
S. Schlossman
|
8 |
1985 |
8
🐬
|
|
🐬
|
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.
E. Reinherz,
C. Morimoto,
K. Fitzgerald,
R. Hussey,
J. Daley,
S. Schlossman
|
8 |
1982 |
8
🐬
|
|
🐜
|
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
7 auth.
C. Morimoto,
D. Hafler,
H. Weiner,
N. Letvin,
M. Hagan,
J. Daley,
...
S. Schlossman
|
8 |
1987 |
8
🐜
|
|
🐜
|
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
10 auth.
T. Hercend,
J. Griffin,
A. Bensussan,
R. Schmidt,
M. Edson,
A. Brennan,
...
C. Murray,
J. Daley,
S. Schlossman,
J. Ritz
|
7 |
1985 |
7
🐜
|
|
🐜
|
Dysfunctional T regulatory cells in multiple myeloma.
12 auth.
R. Prabhala,
P. Neri,
J. Bae,
P. Tassone,
M. Shammas,
C. Allam,
...
J. Daley,
D. Chauhan,
E. Blanchard,
H. Thatte,
K. Anderson,
N. Munshi
|
7 |
2006 |
7
🐜
|
|
🐬
|
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype
R. Schmidt,
C. Murray,
J. Daley,
S. Schlossman,
J. Ritz
|
7 |
1986 |
7
🐬
|
